TipRanks
Advertisement
Advertisement
Starling Oncology Institute: Robust Q2, Raised FY26 Outlook and Expanded Delegated Contracts Support Buy Rating and Unchanged $7 Price Target
PremiumRatingsStarling Oncology Institute: Robust Q2, Raised FY26 Outlook and Expanded Delegated Contracts Support Buy Rating and Unchanged $7 Price Target
2M ago
Starling Oncology price target raised to $11 from $8 at B. Riley
Premium
The Fly
Starling Oncology price target raised to $11 from $8 at B. Riley
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―